Zobrazeno 1 - 10
of 147
pro vyhledávání: '"LI-MIN ZHAO"'
Autor:
Ting-Ting Yang, Pen-Ju Liu, Qing-Yu Sun, Ze-Yi Wang, Guo-Bin Yuan, Ze-Xin Fan, Lin Ma, Jian-Feng Lu, Bo-Yi Yuan, Wen-Long Zou, Li-Min Zhao, Qian Li, Guang-Zhi Liu
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-13 (2024)
Abstract CD4+CD25+ regulatory T cells (Tregs) play an important role in maintaining immune homeostasis in multiple sclerosis (MS). Hence, we aimed to explore the therapeutic efficacy and safety of adoptive cell therapy (ACT) utilizing induced antigen
Externí odkaz:
https://doaj.org/article/82f6f75197fa4f7d83c8e674f2055c70
Publikováno v:
Acta Pharmaceutica Sinica B, Vol 13, Iss 12, Pp 4906-4917 (2023)
Following on our recently developed biphenyl-ATDP non-nucleoside reverse transcriptase inhibitor ZLM-66 (SI = 2019.80, S = 1.9 μg/mL), a series of novel heterocycle-substituted ATDP derivatives with significantly improved selectivity and solubility
Externí odkaz:
https://doaj.org/article/9fc6b09d87c44d3a900c1f299690c817
Autor:
Jin-Lan Zhang, Yu-Huan Li, Lu-Lu Wang, Hong-Qi Liu, Shuai-Yao Lu, Yong Liu, Ke Li, Bin Liu, Su-Yun Li, Feng-Min Shao, Kun Wang, Ning Sheng, Rui Li, Jin-Jin Cui, Pei-Chun Sun, Chun-Xia Ma, Bo Zhu, Zhe Wang, Yuan-Hao Wan, Shi-Shan Yu, Yongsheng Che, Chao-Yang Wang, Chen Wang, Qiangqian Zhang, Li-Min Zhao, Xiao-Zhong Peng, Zhenshun Cheng, Jun-Biao Chang, Jian-Dong Jiang
Publikováno v:
Signal Transduction and Targeted Therapy, Vol 6, Iss 1, Pp 1-15 (2021)
Abstract Azvudine (FNC) is a nucleoside analog that inhibits HIV-1 RNA-dependent RNA polymerase (RdRp). Recently, we discovered FNC an agent against SARS-CoV-2, and have taken it into Phase III trial for COVID-19 patients. FNC monophosphate analog in
Externí odkaz:
https://doaj.org/article/2b9e28f6b8454fbc95a8d8fb4f08409e
Autor:
Yan-Long Ren, Tao-Tao Li, Wei Cui, Li-Min Zhao, Na Gao, Hua Liao, Jiang-Hui Zhang, Jun-Ming Zhu, Zhi-Yu Qiao, Shi-Chao Guo, Li-Li Pan
Publikováno v:
Scientific Reports, Vol 11, Iss 1, Pp 1-9 (2021)
Abstract Interferon-gamma (IFN-γ) is a cytokine involved in the pathogenesis of Takayasu’s arteritis (TAK). However, the source of IFN-γ in TAK patients is not fully clear. We aimed to investigate the source of IFN-γ in TAK. 60 TAK patients and
Externí odkaz:
https://doaj.org/article/83c8575454c34d4db7b552f7e80e11e4
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2022)
Externí odkaz:
https://doaj.org/article/55905f66351546319b7be68f1f5c5d2a
Publikováno v:
Frontiers in Pharmacology, Vol 12 (2022)
Externí odkaz:
https://doaj.org/article/935d36f9278b44e8931e2a23b78a61ee
Publikováno v:
Frontiers in Endocrinology, Vol 12 (2021)
Recently, Lin and colleagues assessed the safety of sodium-glucose cotransporter 2 inhibitors (SGLT2is) by a meta-analysis [1], in which the authors assessed 16 kinds of adverse events (AE) reported in the published articles based on 10 randomized co
Externí odkaz:
https://doaj.org/article/92f0a8df3a5f4ff69f8ca5684258a336
Autor:
Mei Qiu, Li-Min Zhao
Publikováno v:
Frontiers in Cardiovascular Medicine, Vol 8 (2021)
Externí odkaz:
https://doaj.org/article/911938477ff74e469abff0524bea42fe
Publikováno v:
Therapeutic Advances in Endocrinology and Metabolism, Vol 12 (2021)
Background: The effects of sodium-glucose transporter 2 (SGLT2) inhibitors on cardiovascular death (CV death) and all-cause death (AC death) in patients with type 2 diabetes (T2D) and chronic kidney disease (CKD) are currently under intensive investi
Externí odkaz:
https://doaj.org/article/f36ba73981b246e093e669dc90f18dbc
Publikováno v:
Frontiers in Medicine, Vol 8 (2021)
Non-tuberculou Mycobacteria (NTM) is ubiquitous in the environment and is conditional pathogen. Due to NTM and Mycobacterium tuberculosis belong to the genus Mycobacterium, their pathogenic mechanisms and clinical manifestations are similar. Therefor
Externí odkaz:
https://doaj.org/article/2a11c7e27eec4f62b8512e72a7faa8e6